These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28186329)

  • 1. Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability.
    Chung WK; Russell B; Yang Y; Handlogten M; Hudak S; Cao M; Wang J; Robbins D; Ahuja S; Zhu M
    Biotechnol Bioeng; 2017 Jun; 114(6):1264-1274. PubMed ID: 28186329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing process.
    Du C; Huang Y; Borwankar A; Tan Z; Cura A; Yee JC; Singh N; Ludwig R; Borys M; Ghose S; Mussa N; Li ZJ
    MAbs; 2018 Apr; 10(3):500-510. PubMed ID: 29336721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Air sparging for prevention of antibody disulfide bond reduction in harvested CHO cell culture fluid.
    Mun M; Khoo S; Do Minh A; Dvornicky J; Trexler-Schmidt M; Kao YH; Laird MW
    Biotechnol Bioeng; 2015 Apr; 112(4):734-42. PubMed ID: 25384896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing.
    Trexler-Schmidt M; Sargis S; Chiu J; Sze-Khoo S; Mun M; Kao YH; Laird MW
    Biotechnol Bioeng; 2010 Jun; 106(3):452-61. PubMed ID: 20178122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione and thioredoxin systems contribute to recombinant monoclonal antibody interchain disulfide bond reduction during bioprocessing.
    Handlogten MW; Zhu M; Ahuja S
    Biotechnol Bioeng; 2017 Jul; 114(7):1469-1477. PubMed ID: 28262915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic understanding of disulfide reduction during monoclonal antibody production.
    Cura AJ; Xu X; Egan S; Aron K; Jenkins L; Hageman T; Huang Y; Chollangi S; Borys M; Ghose S; Li ZJ
    Appl Microbiol Biotechnol; 2020 Nov; 104(22):9655-9669. PubMed ID: 32997205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of depth filtration on disulfide bond reduction during downstream processing of monoclonal antibodies from CHO cell cultures.
    O'Mara B; Gao ZH; Kuruganti M; Mallett R; Nayar G; Smith L; Meyer JD; Therriault J; Miller C; Cisney J; Fann J
    Biotechnol Bioeng; 2019 Jul; 116(7):1669-1683. PubMed ID: 30883673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-column disulfide bond formation of monoclonal antibodies during Protein A chromatography eliminates low molecular weight species and rescues reduced antibodies.
    Tan Z; Ehamparanathan V; Ren T; Tang P; Hoffman L; Kuang J; Liu P; Huang C; Du C; Tao L; Chemmalil L; Lewandowski A; Ghose S; Li ZJ; Liu S
    MAbs; 2020; 12(1):1829333. PubMed ID: 33016217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell culture media impact on drug product solution stability.
    Purdie JL; Kowle RL; Langland AL; Patel CN; Ouyang A; Olson DJ
    Biotechnol Prog; 2016 Jul; 32(4):998-1008. PubMed ID: 27111574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of enzymatic reduction on bivalent bispecific antibody fragmentation and loss of product purity upon reoxidation.
    Swope N; Chung WK; Cao M; Motabar D; Liu D; Ahuja S; Handlogten M
    Biotechnol Bioeng; 2020 Apr; 117(4):1063-1071. PubMed ID: 31930476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and kinetic modeling of interchain disulfide bond reoxidation of monoclonal antibodies in bioprocesses.
    Tang P; Tan Z; Ehamparanathan V; Ren T; Hoffman L; Du C; Song Y; Tao L; Lewandowski A; Ghose S; Li ZJ; Liu S
    MAbs; 2020; 12(1):1829336. PubMed ID: 33031716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of an analytical approach to assess an antibody's potential for disulfide reduction.
    Yang Y; Bastani N; Lagler SK; Harris D; Nagy A; Chen P; Patel A; Li Y; Gowetski DB; Lei QP
    Biotechnol Prog; 2022 Mar; 38(2):e3229. PubMed ID: 34962716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Untargeted proteomics reveals upregulation of stress response pathways during CHO-based monoclonal antibody manufacturing process leading to disulfide bond reduction.
    Park SY; Egan S; Cura AJ; Aron KL; Xu X; Zheng M; Borys M; Ghose S; Li Z; Lee K
    MAbs; 2021; 13(1):1963094. PubMed ID: 34424810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of antibody reduction in cell culture production processes.
    Kao YH; Hewitt DP; Trexler-Schmidt M; Laird MW
    Biotechnol Bioeng; 2010 Nov; 107(4):622-32. PubMed ID: 20589844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Online control of cell culture redox potential prevents antibody interchain disulfide bond reduction.
    Handlogten MW; Wang J; Ahuja S
    Biotechnol Bioeng; 2020 May; 117(5):1329-1336. PubMed ID: 31956991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest.
    Derfus GE; Dizon-Maspat J; Broddrick JT; Velayo AC; Toschi JD; Santuray RT; Hsu SK; Winter CM; Krishnan R; Amanullah A
    MAbs; 2014; 6(3):679-88. PubMed ID: 24552690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of antibody disulfide reduction and re-oxidation and impact to biological activities.
    Wang T; Liu YD; Cai B; Huang G; Flynn GC
    J Pharm Biomed Anal; 2015 Jan; 102():519-28. PubMed ID: 25459952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast and scalable purification of a therapeutic full-length antibody based on process crystallization.
    Smejkal B; Agrawal NJ; Helk B; Schulz H; Giffard M; Mechelke M; Ortner F; Heckmeier P; Trout BL; Hekmat D
    Biotechnol Bioeng; 2013 Sep; 110(9):2452-61. PubMed ID: 23532914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product.
    Bee JS; Tie L; Johnson D; Dimitrova MN; Jusino KC; Afdahl CD
    Biotechnol Prog; 2015; 31(5):1360-9. PubMed ID: 26259961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.